Literature DB >> 6768217

99mTc labelled human leukocytes. An in vitro functional study.

N Linhart, B Bok, M Gougerot, M T Gaillard, M Meignan.   

Abstract

A new method of human leukocyte labelling is described. 20 ml of human blood are allowed to sediment in a dextran solution and the remaining red blood cells are removed using NH4C1. The leukocyte-rich suspension is incubated with a Sn-pyrophosphate solution, and then labelled, using 20 mCi 99mTc pertechnetate. Labelling efficiency is about 30%. Functional activity was shown to be satisfactory: (1) appearance under electron microscopy was quite normal; (2) Klebsiella ingestion, zymosan-stimulated oxygen consumption and iodination were similar in labelled and unlabelled cells, and (3) chemotaxis revealed no alteration in cell migration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768217     DOI: 10.1159/000207374

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  5 in total

1.  Isolation and labelling of human leukocytes with 99mTc.

Authors:  H Kelbaek
Journal:  Eur J Nucl Med       Date:  1986

2.  Scintigraphic demonstration of subcutaneous abscesses with 99mTc-labeled leukocytes.

Authors:  H Kelbaek; J Fogh; T Gjørup; K Bülow; B Vestergaard
Journal:  Eur J Nucl Med       Date:  1985

3.  111Indium-tropolone labeled human PMNs: a rapid method of preparation and evaluation of labeling parameters.

Authors:  D Bandyopadhyay; R G Schiff; S Hoory; G W Moskowitz; L M Levy; D K Das
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

Review 4.  Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging.

Authors:  Peter J Gawne; Francis Man; Philip J Blower; Rafael T M de Rosales
Journal:  Chem Rev       Date:  2022-05-12       Impact factor: 72.087

5.  Evaluation of a new leukocyte labeling procedure with 99mTc-HMPAO.

Authors:  H Kelbaek; J Linde; S L Nielsen
Journal:  Eur J Nucl Med       Date:  1988
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.